Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Miguel A Lanaspa Garcia

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Phone720/355-0141

    Collapse Research 
    Collapse research activities and funding
    R21AG091650     (BRUCE, KIMBERLEY D)Sep 30, 2024 - Aug 31, 2026
    NIH
    Does GLUT5-mediated Fructose Metabolism drive Microglial Dysfunction in Aging and Alzheimer's Disease?
    Role: Co-Principal Investigator

    R01DK121496     (LANASPA GARCIA, MIGUEL ANGEL)Jan 1, 2020 - Dec 31, 2024
    NIH
    A Novel Role for Vasopressin in Fructose-Induced Metabolic Syndrome
    Role: Co-Principal Investigator

    R21HD096228     (FRANK, DANIEL N)May 9, 2019 - May 8, 2021
    NIH
    Contributions of perinatal sugar exposure to childhood metabolic syndrome
    Role: Co-Principal Investigator

    R01DK108859     (LANASPA GARCIA, MIGUEL ANGEL)Apr 1, 2016 - Mar 31, 2021
    NIH
    Targeting fructokinase, endogenous fructose production and purine degradation for the prevention and treatment of hereditary fructose intolerance
    Role: Principal Investigator

    R03DK105041     (LANASPA GARCIA, MIGUEL ANGEL)Mar 1, 2015 - Dec 31, 2017
    NIH
    A novel Role for endogenous fructose production and metabolism in the pathogenesis of contrast-induced nephropathy
    Role: Principal Investigator

    K01DK095930     (LANASPA GARCIA, MIGUEL ANGEL)Aug 1, 2012 - Sep 30, 2017
    NIH
    A novel role for endogenous fructose in ischemic acute kidney injury
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Andres-Hernando A, Orlicky DJ, Kuwabara M, Fini MA, Tolan DR, Johnson RJ, Lanaspa MA. Activation of AMPD2 drives metabolic dysregulation and liver disease in mice with hereditary fructose intolerance. Commun Biol. 2024 07 11; 7(1):849. PMID: 38992061.
      View in: PubMed
    2. Andres-Hernando A, Orlicky DJ, Kuwabara M, Ishimoto T, Nakagawa T, Johnson RJ, Lanaspa MA. Deletion of Fructokinase in the Liver or in the Intestine Reveals Differential Effects on Sugar-Induced Metabolic Dysfunction. Cell Metab. 2020 07 07; 32(1):117-127.e3. PMID: 32502381.
      View in: PubMed
    Lanaspa Garcia's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)